Life ScienceCompany
Syntimmune Ownership
Who owns Syntimmune?
Syntimmune is owned by Alexion Pharmaceuticals. It was acquired on September 26, 2018.
Syntimmune Business Overview
Where is Syntimmune headquartered?
Syntimmune is headquartered in Boston, Massachusetts.
What sector is Syntimmune in?
Syntimmune is a life science company.
When was Syntimmune founded?
Syntimmune was founded in 2013.
Life Science M&A Summary in 2018
Out of 60 sectors in the Mergr database, life science ranked 7 in number of deals in 2018. The largest life science acquisition in 2018 was Shire - which was acquired by Takeda Pharmaceutical for $67.7B.
Join Mergr to view all 246 acquisitions of life science companies in 2018, including 44 acquisitions by private equity firms, and 202 by strategics.